Tag: diagnostic-products

Commercial & Investment Banking Picture Gallery

Akers Biosciences Announces Q2 2017 Earnings

August 15, 2017
Presse

Total Revenues for Q2 Up 25%

Continue Reading
Commercial & Investment Banking Picture Gallery

Akers Biosciences Announces Pricing of Public Offering of 1,667,000 Shares and 833,500 Warrants

January 10, 2017
Presse

THOROFARE, NJ -- (Marketwired) -- 01/09/17 -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company"…

Continue Reading